Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership

FHS
July 13, 2023
1:13 pm

Evotec SE today announced that Bristol Myers Squibb Company has exercised its option to enter into an exclusive global licence agreement.

Blood-brain barrier model may lead to prevention of meningitis in newborns

Investigators in Israel and Italy have developed a model of the blood-brain barrier, studies of which may lead to prevention of meningitis in newborns.

June 22, 2023

Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million – Biotech Investments

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Financing Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds

March 15, 2024

Omega-3 Supplements Show Benefit in APOE4 Carriers

High-dose supplements of docosahexaenoic acid (DHA), an omega-3 fatty acid, penetrated the brain in both APOE4 carriers and non-carriers before dementia onset, the placebo-controlled PreventE4

November 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.